Prelude Therapeutics Statistics
Total Valuation
PRLD has a market cap or net worth of $216.10 million. The enterprise value is $130.67 million.
Important Dates
The last earnings date was Tuesday, March 10, 2026, before market open.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PRLD has 63.00 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Current Share Class | 48.27M |
| Shares Outstanding | 63.00M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +4.70% |
| Owned by Insiders (%) | 5.34% |
| Owned by Institutions (%) | 9.73% |
| Float | 14.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.80 |
| Forward PS | n/a |
| PB Ratio | 4.12 |
| P/TBV Ratio | 3.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.76 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.99, with a Debt / Equity ratio of 0.26.
| Current Ratio | 1.99 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -99.45% and return on invested capital (ROIC) is -54.72%.
| Return on Equity (ROE) | -99.45% |
| Return on Assets (ROA) | -40.74% |
| Return on Invested Capital (ROIC) | -54.72% |
| Return on Capital Employed (ROCE) | -116.92% |
| Weighted Average Cost of Capital (WACC) | 8.36% |
| Revenue Per Employee | $92,672 |
| Profits Per Employee | -$759,527 |
| Employee Count | 131 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +360.53% in the last 52 weeks. The beta is 0.87, so PRLD's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +360.53% |
| 50-Day Moving Average | 2.51 |
| 200-Day Moving Average | 1.60 |
| Relative Strength Index (RSI) | 61.19 |
| Average Volume (20 Days) | 354,877 |
Short Selling Information
The latest short interest is 2.27 million, so 3.61% of the outstanding shares have been sold short.
| Short Interest | 2.27M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 3.61% |
| Short % of Float | 15.50% |
| Short Ratio (days to cover) | 6.50 |
Income Statement
In the last 12 months, PRLD had revenue of $12.14 million and -$99.50 million in losses. Loss per share was -$1.29.
| Revenue | 12.14M |
| Gross Profit | 12.14M |
| Operating Income | -103.27M |
| Pretax Income | -99.50M |
| Net Income | -99.50M |
| EBITDA | -101.56M |
| EBIT | -103.27M |
| Loss Per Share | -$1.29 |
Full Income StatementBalance Sheet
The company has $103.21 million in cash and $17.79 million in debt, with a net cash position of $85.43 million or $1.36 per share.
| Cash & Cash Equivalents | 103.21M |
| Total Debt | 17.79M |
| Net Cash | 85.43M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 68.64M |
| Book Value Per Share | 0.83 |
| Working Capital | 52.70M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$56.30 million and capital expenditures -$67,000, giving a free cash flow of -$56.37 million.
| Operating Cash Flow | -56.30M |
| Capital Expenditures | -67,000 |
| Free Cash Flow | -56.37M |
| FCF Per Share | -$0.89 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -850.63% |
| Pretax Margin | -819.59% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRLD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.52% |
| Earnings Yield | -46.04% |
| FCF Yield | -26.08% |
Analyst Forecast
The average price target for PRLD is $4.67, which is 36.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.67 |
| Price Target Difference | 36.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 53.07% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PRLD has an Altman Z-Score of -7.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.92 |
| Piotroski F-Score | 2 |
